THE CLINICAL SIGNIFICANCE OF ALLOSPECIFIC ANTIBODIES AGAINST ENDOTHELIAL CELLS DETECTED WITH AN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ASSAY FOR VASCULAR REJECTION AND GRAFT LOSS AFTER RENAL TRANSPLANTATION
- 1 June 1993
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Transplantation
- Vol. 55 (6), 1287-1293
- https://doi.org/10.1097/00007890-199306000-00015